Friday's Small-Cap Winners & Losers
Microvision (MVIS) was on the rise after research firm MDB Capital Group initiated coverage of the company with a buy rating. Microvision, a producer of light scanning technologies for display and imaging products, was gaining 10.3% to $3.01.
Metabolix (MBLX) was rising after naming Matthew Strobeck and Robert Van Nostrand to its board. Strobeck is a senior investment analyst at Westfield Capital Management. He previously served as a consultant to the senior economic adviser to the commissioner of the Food and Drug Administration. Van Nostrand is the senior vice president and chief compliance officer of OSI Pharmaceuticals (OSIP). Shares were up 10.6% to $19.25.
Virco (VIR) surged after the company said third-quarter sales increased 4.5% from last year and that it swung to a profit. Sales reached $73.7 million, up from $70.5 million last year. Virco earned $5.8 million, or 41 cents a share, compared with a loss of $2.2 million and 17 cents a share last year. The company said it expects to incur a loss in the fourth quarter but that it will be narrower than last year's. Shares were gaining 17.8% to $7.55.
Unifi (UFI) slumped after it cut its expectations for the December quarter. The company previously forecast earnings before interest, taxes, depreciation and amortization of $10 million to $12 million, but now it expects actual results to be less than 50% of the original guidance. Unifi was down 28.5% at $1.73.Corriente Resources (ETQ) was dropping after it said it will temporarily suspend work at its Mirador project in Ecuador because of protests near the site. After a number of ineffective talks with the protesters, the government has asked Corriente to temporarily halt its Mirador activities to help in the negotiating process. Shares were losing 13% to $3.90.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV